Pharmaceutical company Merck & Co. has announced that the Food and Drug Administration is officially reviewing the safety and effectiveness of its integrase inhibitor Isentress (raltegravir). An approval is expected by mid-October of this year.
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."